Novel Mitochondria-targeted Drugs for Cancer Therapy

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

LEISCHNER FIALOVÁ Jindřiška RAUDENSKÁ Martina JAKUBEK Milan KEJIK Zdenek MARTÁSEK Pavel BABULA Petr MATKOWSKI Adam FILIPENSKY Petr MASAŘÍK Michal

Year of publication 2021
Type Article in Periodical
Magazine / Source Mini-reviews in medicinal chemistry
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.eurekaselect.com/188152/article
Doi http://dx.doi.org/10.2174/1389557520666201118153242
Keywords Mitochondria; targeting; metabolism; cancer; treatment; inhibitors; hexokinase; tricarboxylic acid cycle; respiratory chain; electron transport chain
Description The search for mitochondria-targeted drugs has dramatically risen over the last decade. Mitochondria are essential organelles serving not only as a powerhouse of the cell but also as a key player in cell proliferation and cell death. Their central role in the energetic metabolism, calcium homeostasis and apoptosis makes them an intriguing field of interest for cancer pharmacology. In cancer cells, many mitochondrial signaling and metabolic pathways are altered. These changes contribute to cancer development and progression. Due to changes in mitochondrial metabolism and changes in membrane potential, cancer cells are more susceptible to mitochondria-targeted therapy. The loss of functional mitochondria leads to the arrest of cancer progression and/or a cancer cell death. Identification of mitochondrial changes specific for tumor growth and progression, rational development of new mitochondria-targeted drugs and research on delivery agents led to the advance of this promising area. This review will highlight the current findings in mitochondrial biology, which are important for cancer initiation, progression and resistance, and discuss approaches of cancer pharmacology with a special focus on the anti-cancer drugs referred to as ‘mitocans’.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.